ACME Solar Holdings Vs Sagility India: What’s a better IPO to bet on?

ACME Solar Holdings and Sagility India launched their IPOs in the first week of November. Sagility India has raised Rs 2,106.60 crore while ACME Solar Holdings has aimed to raise Rs 2,900 crore. The former is purely an OFS while the latter is a combination of fresh issue and OFS. Are you confused about which one to choose? Here are some points to look at:

ACME Solar Holdings on valuation front

The company has a price-to-book value of 7.77. To compare, Adani Green Energy has a P/BV of 25 while the recently listed Waree Energies has a P/BV of 56.68.

Another key ratio price to earnings of ACME Solar Holdings stands at 30.17x at the upper price band. To compare with peers, Adani Green Energy has a P/E ratio of 234.4x while Waree Energies has 90.04x. The industry’s P/E ratio stands at 130.71x.

Its earnings per share before IPO is 13.36 and post-IPO 0.09. Adani Green Energy’s EPS stands at 8 while that of Waaree Energies comes in at 44. 

About ACME Solar Holdings 

ACME Solar Holdings is a large renewable energy player well positioned to capitalize on strong industry tailwinds with end-to-end value chain capabilities and an integrated approach to developing renewable power projects by in-house project development, engineering, procurements, construction, operations and maintenance teams. The company has an expansive portfolio diversified across different renewable energy technologies with long-term stable cash flows based on contracts with central and state government entities along with design and value engineering leading to higher efficiencies.

“…with an EV/EBITDA of 22.4x and market cap of Rs 17,486.8 crore post issue of equity shares and a return on net worth of 26.93%. We believe that the IPO is richly priced and recommend a “Subscribe-Long term” rating to the IPO,” said Anand Rathi Research in an IPO report. 

Sagility India on Valuation Front

The company’s price-to-book value stands at 2 and price-to-earnings at 61.52. Sagility India’s debt-to-equity stands at 0.15 and earnings per share at 0.5 times. 

About Sagility India 

Sagility India specializes in healthcare technology services, strategically positioned at the intersection of healthcare and digital innovation. With a focused approach in this dynamic sector, the company has attracted strong investor interest, including pre-IPO funding from notable backers such as Adani Properties.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s